drugset / Trial / NCT02287584
Confirmatory Study of DSP-5423P in Patients With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study is to evaluate the efficacy of DSP-5423P compared with placebo in patients with schizophrenia.
Timeline
- Start
- 2014-12
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Blonanserin | Small molecule | 20 mg | Other |
| Subject | Blonanserin | Small molecule | 40 mg | Other |
| Subject | Blonanserin | Small molecule | 60 mg | Other |
| Subject | Blonanserin | Small molecule | 80 mg | Other |